StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA) rises on FT report about bird flu vaccines
May 30, 2024 7:40 AM
Shares of Moderna (NASDAQ: MRNA) are up 2.8% premarket Thursday after a report from The Financial Times said US government ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Hot List
Rumors
Next Articles
Moderna (MRNA) PT Raised to $160 at RBC Capital
June 3, 2024 6:40 AM
Moderna (MRNA) up 4% on report US is nearing a deal to green light a late-stage trial of mRNA pandemic bird flu vaccine
May 30, 2024 6:42 AM